Honestly, I'm not sure what to expect. I can only assume that if there are no other funding strategies playing out in the background right now, we need to dilute further. At .25/share, that is really ugly. I would expect funding to be sought in increments with hopes that share price can rebound in the meantime. At .25 price, $70M is another 280M shares, so current shareholders get their percentage of the company diluted down to 0.4 times their current ownership if they try to do it all at once.
It would not surprise me if certain topics such as dilution are left out of the AGM discussion unless someone asks specifically about them. Given that the voting includes authorization for the reverse split, I assume that will be addressed, and with sufficient positive spin. The AGM is their opportunity to explain why they need it and how it will help; they might not delve too deeply into the risks it also poses. I'm not saying this to be critical of current management, I just think it is a fairly natural expectation given their situation.
I think we need to try to drive home the point to them that if this project is really about the technology (as most of us believe) then we need to see some indication of the technology. We need to see evidence that this device is capable of doing what it is expected to do, at least to the extent they can share such evidence. I know there are substantial limitations on what they are allowed to claim about a non-FDA approved device. But if they have surgeons playing with the device, get a couple statements from these docs, have the statements vetted by the legal team, and put them out there to show that SPORT is the real deal and will be as desirable to the marketplace as we all hope it will be. Until we can get some public verification that this is what it looks like, the share price will continue to flounder in the 20 cent range and continue to get played by the shorters and market makers.
All just my opinion, obviously...
